Bipolar Disorder Therapeutics Market

Bipolar Disorder Therapeutics Market Analysis by Type, by Mechanism of Action (MOA), by Dosage Form, by End-Use and by Region - Forecast 2025 to 2035

Analysis of Bipolar Disorder Therapeutics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Bipolar Disorder Therapeutics Market
  • FACT7280MR
  • 15 May 2025
  • Healthcare
  • 170 Pages
  • 116 Tables
  • 38 Figures

Table of Content

  1. Executive Summary
  2. Market Overview
  3. Market Outlook
  4. Market Trend Analysis, 2025 to 2035
  5. Global Market Analysis and Forecast, 2025 to 2035, by Drug Class
    • Antipsychotics Drugs
    • Anticonvulsants
    • Mood Stabilizers
    • Antidepressant Drugs
    • Anti-anxiety Drugs
  6. Global Market Analysis and Forecast, 2025 to 2035, by Mechanism of Action (MOA)
    • Dopamine Antagonists
    • Serotonin Modulators
    • GABAergic Agents
    • Glutamate Receptor Antagonists
  7. Global Market Analysis and Forecast, 2025 to 2035, by Dosage Form
    • Oral Medications
    • Injectables
    • Transdermal Patches
    • Intranasal Sprays
  8. Global Market Analysis and Forecast, 2025 to 2035, by End-Use
    • Hospitals
    • Outpatient Clinics
    • Home Care
    • Pharmacies
    • Online Pharmacies
  9. Global Market Analysis and Forecast, 2025 to 2035, by Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  10. North America Market Analysis and Forecast, 2025 to 2035
  11. Europe Market Analysis and Forecast, 2025 to 2035
  12. Asia Pacific Market Analysis and Forecast, 2025 to 2035
  13. Latin America Market Analysis and Forecast, 2025 to 2035
  14. Middle East & Africa Market Analysis and Forecast, 2025 to 2035
  15. Competition Landscape
    • Drug Class Mapping
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Astellas Pharma Inc.
    • Allergan plc.
    • Johnson & Johnson
    • GlaxoSmithKline plc.
    • AbbVie Inc.
    • Pfizer Inc.
    • Novartis International AG
    • Gedeon Richter Plc
    • Janssen Pharmaceutica N.V.
    • Otsuka America Pharmaceutical Inc.
    • Sumitomo Dainippon Pharma Co. Ltd.
    • Validus Pharmaceuticals LLC
    • Lundbeck A/S
  16. Assumptions & Acronyms Used
  17. Research Methodology

List Of Table

Table 1: Global Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 2: Global Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 3: Global Market Value (Mn) Analysis, 2025 to 2035

Table 4: Global Market Value (Mn) Analysis, 2025 to 2035

Table 5: Global Market Value (Mn) Forecast, by Region, 2025 to 2035

Table 6: Global Market Value (Mn) Forecast, by Region, 2025 to 2035

Table 7: North America Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 8: North America Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 9: North America Market Value (Mn) Analysis, 2025 to 2035

Table 10: North America Market Value (Mn) Analysis, 2025 to 2035

Table 11: North America Market Value (Mn) Forecast, by Country, 2025 to 2035

Table 12: North America Market Value (Mn) Forecast, by Country, 2025 to 2035

Table 13: U.S. Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 14: U.S. Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 15: U.S. Market Value (Mn) Analysis, 2025 to 2035

Table 16: U.S. Market Value (Mn) Analysis, 2025 to 2035

Table 17: Canada Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 18: Canada Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 19: Canada Market Value (Mn) Analysis, 2025 to 2035

Table 20: Canada Market Value (Mn) Analysis, 2025 to 2035

Table 21: Europe Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 22: Europe Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 23: Europe Market Value (Mn) Analysis, 2025 to 2035

Table 24: Europe Market Value (Mn) Analysis, 2025 to 2035

Table 25: Europe Market Value (Mn) Forecast, by Country and Sub-region, 2025 to 2035

Table 26: Europe Market Value (Mn) Forecast, by Country and Sub-region, 2025 to 2035

Table 27: Germany Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 28: Germany Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 29: Germany Market Value (Mn) Analysis, 2025 to 2035

Table 30: Germany Market Value (Mn) Analysis, 2025 to 2035

Table 31: U.K. Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 32: U.K. Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 33: U.K. Market Value (Mn) Analysis, 2025 to 2035

Table 34: U.K. Market Value (Mn) Analysis, 2025 to 2035

Table 35: France Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 36: France Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 37: France Market Value (Mn) Analysis, 2025 to 2035

Table 38: France Market Value (Mn) Analysis, 2025 to 2035

Table 39: Italy Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 40: Italy Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 41: Italy Market Value (Mn) Analysis, 2025 to 2035

Table 42: Italy Market Value (Mn) Analysis, 2025 to 2035

Table 43: Spain Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 44: Spain Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 45: Spain Market Value (Mn) Analysis, 2025 to 2035

Table 46: Spain Market Value (Mn) Analysis, 2025 to 2035

Table 47: Russia & CIS Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 48: Russia & CIS Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 49: Russia & CIS Market Value (Mn) Analysis, 2025 to 2035

Table 50: Russia & CIS Market Value (Mn) Analysis, 2025 to 2035

Table 51: Rest of Europe Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 52: Rest of Europe Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 53: Rest of Europe Market Value (Mn) Analysis, 2025 to 2035

Table 54: Rest of Europe Market Value (Mn) Analysis, 2025 to 2035

Table 55: Asia Pacific Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 56: Asia Pacific Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 57: Asia Pacific Market Value (Mn) Analysis, 2025 to 2035

Table 58: Asia Pacific Market Value (Mn) Analysis, 2025 to 2035

Table 59: Asia Pacific Market Value (Mn) Forecast, by Country and Sub-region, 2025 to 2035

Table 60: Asia Pacific Market Value (Mn) Forecast, by Country and Sub-region, 2025 to 2035

Table 61: China Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 62: China Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 63: China Market Value (Mn) Analysis, 2025 to 2035

Table 64: China Market Value (Mn) Analysis, 2025 to 2035

Table 65: Japan Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 66: Japan Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 67: Japan Market Value (Mn) Analysis, 2025 to 2035

Table 68: Japan Market Value (Mn) Analysis, 2025 to 2035

Table 69: India Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 70: India Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 71: India Market Value (Mn) Analysis, 2025 to 2035

Table 72: India Market Value (Mn) Analysis, 2025 to 2035

Table 73: ASEAN Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 74: ASEAN Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 75: ASEAN Market Value (Mn) Analysis, 2025 to 2035

Table 76: ASEAN Market Value (Mn) Analysis, 2025 to 2035

Table 77: Rest of Asia Pacific Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 78: Rest of Asia Pacific Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 79: Rest of Asia Pacific Market Value (Mn) Analysis, 2025 to 2035

Table 80: Rest of Asia Pacific Market Value (Mn) Analysis, 2025 to 2035

Table 81: Latin America Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 82: Latin America Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 83: Latin America Market Value (Mn) Analysis, 2025 to 2035

Table 84: Latin America Market Value (Mn) Analysis, 2025 to 2035

Table 85: Latin America Market Value (Mn) Forecast, by Country and Sub-region, 2025 to 2035

Table 86: Latin America Market Value (Mn) Forecast, by Country and Sub-region, 2025 to 2035

Table 87: Brazil Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 88: Brazil Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 89: Brazil Market Value (Mn) Analysis, 2025 to 2035

Table 90: Brazil Market Value (Mn) Analysis, 2025 to 2035

Table 91: Mexico Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 92: Mexico Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 93: Mexico Market Value (Mn) Analysis, 2025 to 2035

Table 94: Mexico Market Value (Mn) Analysis, 2025 to 2035

Table 95: Rest of Latin America Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 96: Rest of Latin America Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 97: Rest of Latin America Market Value (Mn) Analysis, 2025 to 2035

Table 98: Rest of Latin America Market Value (Mn) Analysis, 2025 to 2035

Table 99: Middle East & Africa Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 100: Middle East & Africa Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 101: Middle East & Africa Market Value (Mn) Analysis, 2025 to 2035

Table 102: Middle East & Africa Market Value (Mn) Analysis, 2025 to 2035

Table 103: Middle East & Africa Market Value (Mn) Forecast, by Country and Sub-region, 2025 to 2035

Table 104: Middle East & Africa Market Value (Mn) Forecast, by Country and Sub-region, 2025 to 2035

Table 105: GCC Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 106: GCC Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 107: GCC Market Value (Mn) Analysis, 2025 to 2035

Table 108: GCC Market Value (Mn) Analysis, 2025 to 2035

Table 109: South Africa Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 110: South Africa Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 111: South Africa Market Value (Mn) Analysis, 2025 to 2035

Table 112: South Africa Market Value (Mn) Analysis, 2025 to 2035

Table 113: Rest of Middle East & Africa Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 114: Rest of Middle East & Africa Market Value (Mn) Forecast, by Drug Class, 2025 to 2035

Table 115: Rest of Middle East & Africa Market Value (Mn) Analysis, 2025 to 2035

Table 116: Rest of Middle East & Africa Market Value (Mn) Analysis, 2025 to 2035

List Of Figures

Figure 1: Global Market Price Trend, by Region, 2025 to 2035 (US$/Ton)

Figure 2: Global Market Value Share, by Drug Class, 2025 and 2035

Figure 3: Global Market Attractiveness, by Drug Class

Figure 4: Global Market Value Share, Analysis, 2025 and 2035

Figure 5: Global Market Attractiveness, Analysis

Figure 6: Global Market Value Share, by Region, 2025 and 2035

Figure 7: Global Market Attractiveness, by Region

Figure 8: North America Market Value Share, by Drug Class, 2025 and 2035

Figure 9: North America Market Attractiveness, by Drug Class

Figure 10: North America Market Value Share, Analysis, 2025 and 2035

Figure 11: North America Market Attractiveness, Analysis

Figure 12: North America Market Value Share, by Country, 2025 and 2035

Figure 13: North America Market Attractiveness, by Country

Figure 14: Europe Market Value Share, by Drug Class, 2025 and 2035

Figure 15: Europe Market Attractiveness, by Drug Class

Figure 16: Europe Market Value Share, Analysis, 2025 and 2035

Figure 17: Europe Market Attractiveness, Analysis

Figure 18: Europe Market Value Share, by Country and Sub-region, 2025 and 2035

Figure 19: Europe Market Attractiveness, by Country and Sub-region

Figure 20: Asia Pacific Market Value Share, by Drug Class, 2025 and 2035

Figure 21: Asia Pacific Market Attractiveness, by Drug Class

Figure 22: Asia Pacific Market Value Share, Analysis, 2025 and 2035

Figure 23: Asia Pacific Market Attractiveness, Analysis

Figure 24: Asia Pacific Market Value Share, by Country and Sub-region, 2025 and 2035

Figure 25: Asia Pacific Market Attractiveness, by Country and Sub-region

Figure 26: Latin America Market Value Share, by Drug Class, 2025 and 2035

Figure 27: Latin America Market Attractiveness, by Drug Class

Figure 28: Latin America Market Value Share, Analysis, 2025 and 2035

Figure 29: Latin America Market Attractiveness, Analysis

Figure 30: Latin America Market Value Share, by Country and Sub-region, 2025 and 2035

Figure 31: Latin America Market Attractiveness, by Country and Sub-region

Figure 32: Middle East & Africa Market Value Share, by Drug Class, 2025 and 2035

Figure 33: Middle East & Africa Market Attractiveness, by Drug Class

Figure 34: Middle East & Africa Market Value Share, Analysis, 2025 and 2035

Figure 35: Middle East & Africa Market Attractiveness, Analysis

Figure 36: Middle East & Africa Market Value Share, by Country and Sub-region, 2025 and 2035

Figure 37: Middle East & Africa Market Attractiveness, by Country and Sub-region

Figure 38: Global Market Share Analysis, by Company, 2025

Bipolar Disorder Therapeutics Market

Free Sample Buy Report Now

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services